The Union has been leading the way in knowledge and research sharing around COVID-19 and lung health, including a powerful webinar series, publishing guidance, briefings, journal articles, and a set of frequently asked questions.
FAQs on COVID-19 and lung health
The Union has published a set of frequently asked questions regarding COVID-19 and lung health, focusing on its impact on TB services and the people undergoing TB treatment, and guidance to maintain quality care throughout this period, as well as recommendations and guidance for healthcare workers treating smokers with COVID-19.
Webinar series: COVID-19 and lung health
The COVID-19 pandemic is perhaps the greatest healthcare challenge of a generation. The Union, in collaboration with its global community of members, is pleased to launch an open-access webinar series on COVID-19 and its intersection with tuberculosis (TB), tobacco control, lung disease and more.
See our other webinars here
COVID official guidance
Read official guidance from The Union and our partner organisations on the latest guidance on COVID-19.
IJTLD fast-tracked articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking accepted articles from the International Journal of Tuberculosis and Lung Disease (IJTLD) regarding COVID-19 and publishing them in full on our website, prior to their publication in the Journal.
See a complete list of all of our fast-tracked articles here.
TB research amidst the COVID-19 pandemic
To ensure that scientific research of immediate concern is shared as rapidly as possible, The Union is fast-tracking accepted articles…
Mortality of TB-COVID-19 coinfection in India
To ensure that scientific research of immediate concern is shared as rapidly as possible, The Union is fast-tracking accepted articles…
Tobacco use and quitting behaviour during COVID-19 lockdown
A survey has revealed that nearly two thirds of tobacco users reported an intention to quit smoking during lockdown in Chennai, India.
Urgent call for continuity of TB services during the COVID-19 pandemic in China
Our survey revealed that COVID-19 led to a significant disruption in TB diagnosis and care at major hospitals throughout China. We urgently call for additional investment directed toward improving the availability of diagnostics and therapeutics such that equitable access to care can be maintained during times of crisis.
TB and COVID-19 co-infection: rationale and aims of a global study
The potential impact of COVID-19 on TB patients and services continues to generate significant attention. Although several concerns have been raised, scientific evidence remains modest.
Impact of COVID-19 on TB diagnosis in Northeastern Brazil
In the context of the global pandemic, there is an urgent need for research that elucidates the relationship between COVID-19 and TB, the adoption of strategies that protect TB patients from infection by SARS-CoV-2, and the adoption and/or strengthening of strategies to ensure the diagnosis of TB during the pandemic period.
The latest Union news about COVID-19
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19
In this recently accepted article for IJTLD, the authors found that RR-TB diagnosis decreased by 21–38% following the start of the pandemic. The results are disturbing and suggest that COVID-19 has had a sustained impact at a time when household transmission of TB/RR-TB might have increased due to ‘shelter at home’. The preprint is free to read.
Impact of COVID-19 on TB case detection and treatment outcomes
The Centre for Operational Research at The Union, working in close collaboration with the National TB Programme and National AIDS…
The impact of COVID-19 on TB: a review of the data
In this recently accepted Review for IJTLD, the authors summarise the evidence available at a country level, identifying broad mechanisms by which COVID-19 may modify TB burden and mitigation efforts.
Tackling TB and COVID-19: US leadership is needed on global health, now more than ever
In the lead up to World TB Day, an article in PHA calls for increased funding and renewed leadership to coordinate the global fight against TB. A relatively small investment in TB control has the potential to transform TB care, saving millions of lives and trillions of dollars in the global economy.
Partner sponsored content
The Union presents a series of special webinar sessions, organised and paid for by our partners to showcase new science and new areas of work. All paid for sessions are reviewed for compliance with The Union’s mission and vision.
Past webinar
The twin epidemics of TB and COVID-19: challenges and controversies
Watch a recording of this webinar
This webinar is paid for and created by Oxford Immunotec.
